Multiple Sclerosis Risk Factors

This is a U.S. news story, published by Live Science, that relates primarily to Bifidobacterium news.

U.S. news

For more U.S. news, you can click here:

more U.S. news

Bifidobacterium news

For more Bifidobacterium news, you can click here:

more Bifidobacterium news

biology news

For more biology news, you can click here:

more biology news

Live Science news

For more news from Live Science, you can click here:

more news from Live Science

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best science news, business news, entertainment news, and much more. If you like biology news, you might also like this article about

multiple sclerosis lack gut bacteria

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest multiple sclerosis patients news, gut microbiome news, biology news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

Multiple sclerosis

Live Science

•

Science

Gut bacteria imbalance linked to multiple sclerosis

Summary

Nutrition label

80% Informative

Multiple sclerosis affects nearly one million people in the U.S. and over 2.8 million worldwide.

The ratio of two bacteria in the gut can predict multiple sclerosis severity in patients.

The balance between two gut bacteria, Bifidobacterium and Akkermansia , was critical in distinguishing mice with MS-like symptoms.

While more research can help clarify the link between the gut microbiome and multiple sclerosis, these findings offer a promising new direction for understanding and treating this disease. Ashutosh Mangalam is a researcher working to develop better treatment options to cure multiple sclerosis (MS). You must confirm your public display name before commenting Please logout and then login again, you will then be prompted to enter your display name..

VR Score

Informative language

Neutral language

Article tone

informal

Language

English

Language complexity

Offensive language

possibly offensive

Hate speech

not hateful